Viridian Therapeutics
VRDN
VRDN
44 hedge funds and large institutions have $46.1M invested in Viridian Therapeutics in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 2 closing their positions.
Holders
44
Holders Change
+13
Holders Change %
+41.94%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
14
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$2.82M |
2 |
AG
2
Artal Group
Luxembourg
|
$915K |
3 |
BW
3
Biegel & Waller
Columbia,
Maryland
|
$609K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$772K |
5 |
5
BlackRock
New York
|
$5.03M |